The AlgaLab team, comprised of Saana Soppela, Minne Jartti, and Stina Gröhn from Tampere University, won the fifth BioFinland pitching competition held on September 29th at Pörssitalo, Helsinki.

The competition's aim is to inspire students to adopt a positive stance towards biobusiness and entrepreneurship. Finnish Bioindustries FIB organized the competition in collaboration with HiLife and Nasdaq Helsinki as part of the European Biotech Week.

Here are the finalists of the BioFinland Pitching competition for students in Finnish universities and universities of applied sciences:

Aethra
Jakob German, Essi Viippola, Matteo Ferro

AlgaLab
Saana Soppela, Minne Jartti, Stina Gröhn

Obesity Curiosity
Suvi Laitinen

Novel Neuroregenerative Agents
Sven Sakson

Biovian Oy, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, announces a major investment of over €50 million to expand its manufacturing facility in Turku, Finland.

The new facility will cover an area of 6,400 sqm (69,000 sqft), and house cutting-edge equipment and advanced technologies to support the development, manufacturing, and testing of ATMP (Advanced Therapy Medicinal Products), such as adenoviral and AAV (adeno-associated viral) therapies. It will also feature dedicated Class A to D cleanroom areas for bulk drug substances as well as final drug product manufacture. The expanded facility will adhere to current good manufacturing practices (cGMP) and fulfilling both EU and US GMP requirements ensuring the delivery of safe, reliable, and compliant biopharmaceutical products.